(CMBT) CMB.TECH - Ratings and Ratios

Exchange: NYSE • Country: Belgium • Currency: USD • Type: Common Stock • ISIN: BE0003816338

Tankers, Bulk, Container, Hydrogen, Ammonia

Dividends

Dividend Yield 2.12%
Yield on Cost 5y 4.13%
Yield CAGR 5y 40.86%
Payout Consistency 54.4%
Payout Ratio 6.0%
Risk via 10d forecast
Volatility 43.9%
Value at Risk 5%th 68.8%
Relative Tail Risk -4.67%
Reward TTM
Sharpe Ratio 0.14
Alpha -15.23
CAGR/Max DD -0.08
Character TTM
Hurst Exponent 0.417
Beta 0.661
Beta Downside 0.542
Drawdowns 3y
Max DD 57.21%
Mean DD 21.50%
Median DD 11.98%

Description: CMBT CMB.TECH November 13, 2025

Cmb.Tech NV (NYSE:CMBT) is a Belgian-based marine transportation group that operates three distinct divisions: Marine, H2 Infra and H2 Industry. The Marine arm manages a diversified fleet-including crude oil tankers, bulk carriers, container ships, chemical carriers, offshore-wind support vessels, tugboats and ferries-totaling roughly 30 vessels with an aggregate deadweight of ~4 million tons, positioning the company within the GICS “Oil & Gas Storage & Transportation” sub-industry.

The H2 Infra division focuses on the emerging green-hydrogen value chain, securing low-carbon feedstock (e.g., renewable electricity) to produce and distribute hydrogen and ammonia, while the H2 Industry segment supplies dual-fuel solutions that enable existing marine and industrial engines to run on a blend of conventional fuel and green hydrogen, a capability that could benefit from the EU’s 2030 hydrogen roadmap targeting 40 GW of electrolyzer capacity.

Formerly Euronav NV, the firm rebranded to Cmb.Tech NV in October 2024 after a strategic pivot toward decarbonization; it remains a wholly-owned subsidiary of CMB NV and retains its Antwerp headquarters, a hub for European shipping and logistics.

Key market drivers include volatile bunker fuel prices, tightening IMO 2023 global sulphur cap compliance costs, and accelerating demand for low-carbon marine fuels-factors that together could pressure traditional tanker margins but create upside for firms with dual-fuel capabilities.

For a deeper dive into how Cmb.Tech’s hybrid business model stacks up against sector peers, you might explore the analytics on ValueRay to assess its valuation sensitivity to hydrogen-related policy shifts.

Piotroski VR‑10 (Strict, 0-10) 3.0

Net Income (164.8m TTM) > 0 and > 6% of Revenue (6% = 78.2m TTM)
FCFTA -0.11 (>2.0%) and ΔFCFTA -7.05pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue -17.32% (prev 12.02%; Δ -29.34pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.04 (>3.0%) and CFO 327.8m > Net Income 164.8m (YES >=105%, WARN >=100%)
Net Debt (5.53b) to EBITDA (764.8m) ratio: 7.24 <= 3.0 (WARN <= 3.5)
Current Ratio 0.73 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (238.5m) change vs 12m ago 22.80% (target <= -2.0% for YES)
Gross Margin 35.47% (prev 44.26%; Δ -8.79pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 21.74% (prev 27.30%; Δ -5.57pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 1.15 (EBITDA TTM 764.8m / Interest Expense TTM 377.9m) >= 6 (WARN >= 3)

Altman Z'' 0.75

(A) -0.03 = (Total Current Assets 597.2m - Total Current Liabilities 822.9m) / Total Assets 8.37b
(B) 0.08 = Retained Earnings (Balance) 662.7m / Total Assets 8.37b
(C) 0.07 = EBIT TTM 435.1m / Avg Total Assets 5.99b
(D) 0.17 = Book Value of Equity 1.01b / Total Liabilities 5.82b
Total Rating: 0.75 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 42.23

1. Piotroski 3.0pt
2. FCF Yield -11.34%
3. FCF Margin -72.21%
4. Debt/Equity 2.20
5. Debt/Ebitda 7.24
6. ROIC - WACC (= 2.49)%
7. RoE 10.38%
8. Rev. Trend 62.08%
9. EPS Trend 2.78%

What is the price of CMBT shares?

As of December 14, 2025, the stock is trading at USD 9.67 with a total of 2,118,075 shares traded.
Over the past week, the price has changed by -10.55%, over one month by +0.31%, over three months by +1.41% and over the past year by +5.11%.

Is CMBT a buy, sell or hold?

CMB.TECH has received a consensus analysts rating of 5.00. Therefore, it is recommended to buy CMBT.
  • Strong Buy: 1
  • Buy: 0
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the CMBT price?

Issuer Target Up/Down from current
Wallstreet Target Price 11.6 20%
Analysts Target Price 11.6 20%
ValueRay Target Price 9.7 0.6%

CMBT Fundamental Data Overview December 06, 2025

Market Cap EUR = 2.76b (3.24b USD * 0.8518 USD.EUR)
P/E Trailing = 13.1687
P/E Forward = 6.8966
P/S = 2.4872
P/B = 1.2608
P/EG = -3.43
Beta = -0.198
Revenue TTM = 1.30b EUR
EBIT TTM = 435.1m EUR
EBITDA TTM = 764.8m EUR
Long Term Debt = 4.99b EUR (from longTermDebt, last quarter)
Short Term Debt = 622.6m EUR (from shortTermDebt, last quarter)
Debt = 5.62b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.53b EUR (from netDebt column, last quarter)
Enterprise Value = 8.29b EUR (2.76b + Debt 5.62b - CCE 81.9m)
Interest Coverage Ratio = 1.15 (Ebit TTM 435.1m / Interest Expense TTM 377.9m)
FCF Yield = -11.34% (FCF TTM -941.0m / Enterprise Value 8.29b)
FCF Margin = -72.21% (FCF TTM -941.0m / Revenue TTM 1.30b)
Net Margin = 12.64% (Net Income TTM 164.8m / Revenue TTM 1.30b)
Gross Margin = 35.47% ((Revenue TTM 1.30b - Cost of Revenue TTM 840.9m) / Revenue TTM)
Gross Margin QoQ = 49.46% (prev 20.76%)
Tobins Q-Ratio = 0.99 (Enterprise Value 8.29b / Total Assets 8.37b)
Interest Expense / Debt = 1.97% (Interest Expense 110.8m / Debt 5.62b)
Taxrate = 4.78% (868.0k / 18.2m)
NOPAT = 414.3m (EBIT 435.1m * (1 - 4.78%))
Current Ratio = 0.73 (Total Current Assets 597.2m / Total Current Liabilities 822.9m)
Debt / Equity = 2.20 (Debt 5.62b / totalStockholderEquity, last quarter 2.55b)
Debt / EBITDA = 7.24 (Net Debt 5.53b / EBITDA 764.8m)
Debt / FCF = -5.88 (negative FCF - burning cash) (Net Debt 5.53b / FCF TTM -941.0m)
Total Stockholder Equity = 1.59b (last 4 quarters mean from totalStockholderEquity)
RoA = 1.97% (Net Income 164.8m / Total Assets 8.37b)
RoE = 10.38% (Net Income TTM 164.8m / Total Stockholder Equity 1.59b)
RoCE = 6.62% (EBIT 435.1m / Capital Employed (Equity 1.59b + L.T.Debt 4.99b))
RoIC = 6.53% (NOPAT 414.3m / Invested Capital 6.34b)
WACC = 4.04% (E(2.76b)/V(8.38b) * Re(8.45%) + D(5.62b)/V(8.38b) * Rd(1.97%) * (1-Tc(0.05)))
Discount Rate = 8.45% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 8.65%
Fair Price DCF = unknown (Cash Flow -941.0m)
EPS Correlation: 2.78 | EPS CAGR: 85.49% | SUE: 0.04 | # QB: 0
Revenue Correlation: 62.08 | Revenue CAGR: 48.56% | SUE: 1.36 | # QB: 3
EPS next Quarter (2026-03-31): EPS=0.17 | Chg30d=-0.140 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=1.46 | Chg30d=-0.530 | Revisions Net=-1 | Growth EPS=+29100.0% | Growth Revenue=+34.4%

Additional Sources for CMBT Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle